Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (341-350 of 434) with videos related to

Pageof 44
Sort By:
The American Journal of Medicine|July 3, 2007
ANCA are detectable in nearly all patients with active severe Wegener's granulomatosisJavier D Finkielman, Augustine S Lee, Amber M Hummel, et al.
Arthritis and Rheumatism|April 29, 2008
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trialPeter A Merkel, Nancy P Silliman, Christopher P Denton, et al.
Arthritis and Rheumatism|June 3, 2008
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase diseaseArnold E Postlethwaite, Weng Kee Wong, Philip Clements, et al.
Clinical Immunology (Orlando, Fla.)|March 6, 2023
Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitisDespina Michailidou, Runa Kuley, Ting Wang, et al.
Rheumatology (Oxford, England)|July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosisHana Sabanovic, John D Pauling, Murray Baron, et al.
Arthritis and Rheumatism|April 18, 2012
Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritisSharon A Chung, Gang Xie, Delnaz Roshandel, et al.
Annals of the Rheumatic Diseases|August 17, 2024
Plasma proteome profiling in giant cell arteritisKevin Y Cunningham, Benjamin Hur, Vinod K Gupta, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 3, 2016
The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody-Associated VasculitisRodrigo Cartin-Ceba, Divya Indrakanti, Ulrich Specks, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2019
Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody-Associated VasculitisAndreas Kronbichler, Johannes Leierer, Jae Il Shin, et al.
The American Journal of Pathology|April 7, 2020
Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory FeaturesZachary M Dong, Edwin Lin, Michael E Wechsler, et al.
Pageof 44

Showing results (341-350 of 434) with videos related to

Sort By:
Pageof 44
The American Journal of Medicine|July 3, 2007
ANCA are detectable in nearly all patients with active severe Wegener's granulomatosisJavier D Finkielman, Augustine S Lee, Amber M Hummel, et al.
Arthritis and Rheumatism|April 29, 2008
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trialPeter A Merkel, Nancy P Silliman, Christopher P Denton, et al.
Arthritis and Rheumatism|June 3, 2008
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase diseaseArnold E Postlethwaite, Weng Kee Wong, Philip Clements, et al.
Clinical Immunology (Orlando, Fla.)|March 6, 2023
Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitisDespina Michailidou, Runa Kuley, Ting Wang, et al.
Rheumatology (Oxford, England)|July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosisHana Sabanovic, John D Pauling, Murray Baron, et al.
Arthritis and Rheumatism|April 18, 2012
Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritisSharon A Chung, Gang Xie, Delnaz Roshandel, et al.
Annals of the Rheumatic Diseases|August 17, 2024
Plasma proteome profiling in giant cell arteritisKevin Y Cunningham, Benjamin Hur, Vinod K Gupta, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 3, 2016
The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody-Associated VasculitisRodrigo Cartin-Ceba, Divya Indrakanti, Ulrich Specks, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2019
Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody-Associated VasculitisAndreas Kronbichler, Johannes Leierer, Jae Il Shin, et al.
The American Journal of Pathology|April 7, 2020
Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory FeaturesZachary M Dong, Edwin Lin, Michael E Wechsler, et al.
Pageof 44